Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
ABBVIE INC.
AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
IPO Date: December 14, 2012
Sector: Healthcare
Industry: Drug Manufacturers
Market Cap: $329.24B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.99 | 1.02%
Avg Daily Range (30 D): $2.04 | 1.09%
Avg Daily Range (90 D): $2.64 | 1.39%
Institutional Daily Volume
Avg Daily Volume: 6.3M
Avg Daily Volume (30 D): 4.09M
Avg Daily Volume (90 D): 5.34M
Trade Size
Avg Trade Size (Sh.): 107
Avg Trade Size (Sh.) (30 D): 55
Avg Trade Size (Sh.) (90 D): 57
Institutional Trades
Total Inst.Trades: 61,036
Avg Inst. Trade: $9.65M
Avg Inst. Trade (30 D): $30.46M
Avg Inst. Trade (90 D): $27.01M
Avg Inst. Trade Volume: .09M
Avg Inst. Trades (Per Day): 19
Market Closing Trades
Avg Closing Trade: $89.28M
Avg Closing Trade (30 D): $255.6M
Avg Closing Trade (90 D): $257.27M
Avg Closing Volume: 802.12K
   
News
Jul 23, 2025 @ 5:00 PM
Global Dysmenorrhea Treatment Market to Cross ~USD...
Source: Delveinsight
Jul 23, 2025 @ 4:51 PM
Rheumatologists Eye AbbVie’s Rinvoq, Roche/...
Source: Spherix Global Insights
Jul 22, 2025 @ 10:15 AM
2 High-Yield Dividend ETFs That Could Deliver Stea...
Source: Stefon Walters
Jul 19, 2025 @ 10:15 AM
All It Takes Is $2,000 Invested in Each of These H...
Source: Manali Pradhan
Jul 18, 2025 @ 8:58 AM
Ophthalmics Collaboration and Licensing Deals Repo...
Source: Researchandmarkets.Com
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $.72 $.88
Diluted EPS $.72 $.88
Revenue $ $ 13.34B $ 14.46B
Gross Profit $ $ 9.34B $ 10.25B
Net Income / Loss $ $ 1.29B $ 1.56B
Operating Income / Loss $ $ 3.73B $ 3.83B
Cost of Revenue $ $ 4B $ 4.21B
Net Cash Flow $ $ -349M $ -5873M
PE Ratio